article thumbnail

STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database

STAT

The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5

article thumbnail

STAT+: How AI can distort clinical decision-making to prioritize profits over patients

STAT

More than a decade ago, Ken Mandl was on a call with a pharmaceutical company and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test.    The test could determine a patient’s need for a helpful drug.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.

article thumbnail

STAT+: Pharmalittle: We’re reading about Novo Holdings proceeding with Catalent deal, Sanofi threatened with sanctions, and more

STAT

government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceutical company has been threatened with such a step , STAT tells us.

article thumbnail

BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology for biologic drugs

Express Pharma

The biologics market is expected to grow to more than $670 billion(iv) by 2030, and for pharmaceutical companies developing these complex drugs, the BD Libertas Wearable Injector offers a customisable, patient-centric solution.

article thumbnail

Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare

Express Pharma

The gathering brought together senior representatives from hospitals, pharmaceutical companies, policymakers, and ESG leaders, including Fortis, Apollo, Quadria Capital, and Tata Capital Healthcare Fund. The report was released at an event held in New Delhi, supported by Quadria Capital and HealthQuad.

article thumbnail

FDA approves innovative monotherapy for treatment-resistant depression

European Pharmaceutical Review

Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company. At week 4, 22.5 percent of patients taking SPRAVATO achieved remission. This was compared to 7.6